Hepatobiliary Surgery and Nutrition

Article	Citations
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.	149
Neoadjuvant therapy for resectable pancreatic cancers	84
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?	80
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma	69
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations	65
Acute coil migration in upper gastrointestinal bleeding	58
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations	49
The limits of segmental dichotomy: rethinking how we classify and compare minimally invasive liver resections	45
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	44
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology	40
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?	37
Evidence-based strategies of exercise and nutrition in sarcopenia care in liver cirrhosis patients	34
Impact of expert centers annual case volume on outcomes of minimally-invasive liver resections: international multicenter study	33
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers	28
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy	27
Therapeutic advances in hepatocellular carcinoma with portal vein tumor thrombus in the era of immuno-targeted therapy—a narrative review	26
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure	26
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience	24
Single-port robotic pancreaticoduodenectomy with the SHURUI snake-arm system: first clinical application	24
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study	20
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	20
A 7-year-old girl with giant congenital biliary dilatation	20
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”	19
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular	19
Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer	18

Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor	18
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology	18
A proposal to simplify the definition of metabolic dysfunction-associated steatotic liver disease in youths	17
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids	16
Hepatocellular carcinoma surveillance—is it time to update clinical practice?	16
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study	16
Outcomes after surgery for locally advanced pancreatic cancer compared to borderline and upfront resectable pancreatic cancer	16
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?	15
Expert consensus on difficult airway assessment	15
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma	15
Omics-driven biomarker discovery for immune checkpoint inhibitor-based therapy in biliary tract cancer: a narrative review	15
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China	15
Enhancing diagnostic strategies for biliary strictures: an evolving landscape	14
Convergent bioprinting and microfluidics: toward next-generation biomimetic tumor models	14
Adjuvant chemoimmunotherapy vs. capecitabine vs. observation in resected biliary tract cancer: a multi-center retrospective study	14
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	13
Robotic hepatectomy: challenge and progression	13
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics	13
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma	13
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies	12
Beyond the H-index: re-centering the operating room in the evaluation of the surgeon-scientist in hepatobiliary surgery	11
Perioperative management of patients with liver cancer complicated with sarcopenia	11
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease	11
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management	11
Novel biomarkers for hepatocellular carcinoma detection and treatment	11
Does preoperative routine statin use reduce post-hepatectomy liver failure?—an international multicentre retrospective cohort study on 2,342 patients	11
Highlights of constructing liver-relevant in vitro models with 3D bioprinting	11
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial	11
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy	10
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air	10
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine	10
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis	10
Clinical outcomes of hepatectomy after partial response to immune checkpoint inhibitor-based combination therapy in patients with extrahepatic hepatocellular carcinoma metastasis	10
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis	10
Trimming the fat myth: adipose tissue’s role in liver regeneration	10
Should all patients be offered liver venous deprivation for insufficient future liver remnant hypertrophy prior to major hepatectomy?	10
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	9
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data	9
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications	9
Minimally invasive hepatectomy is here to stay, but more evidence is needed	9
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis	9
Refining prognostication in intermediate-stage hepatocellular carcinoma after transarterial chemoembolization: promise and limitations of the proposed NTAA model	9
Deceased donor liver transplant outcomes: does donor drinking matter?	9
“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)	9
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy	9
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	9
Difficulties and opportunities of hospice care—the role of doctors	9
Never change a winning team—liver stiffness measurement and platelet count as key surrogates for clinically significant portal hypertension	9
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients	8
Prioritising preventive approaches for metabolic dysfunction-associated steatohepatitis in high-risk populations: a narrative review	8

Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter	8
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea	8
ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity	8
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones	8
Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future	8
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	8
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?	8
Pushing to resect colorectal liver metastases: rethinking surgical strategy in colorectal liver metastases with extrahepatic spread	8
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering	7
Pediatric ex-vivo liver resection and auto-transplantation for complex hepatic alveolar echinococcosis	7
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	7
Novel preoperative strategies to improve hepatocellular carcinoma resectability	7
Preoperative prediction of microvascular invasion in hepatocellular carcinoma: an umbrella review of systematic reviews and meta-analyses with etiology-specific implications	7
Application progress of spatial omics in hepatobiliary tumor research	7
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives	7
Alcohol-related liver disease	7
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial	7
Validation of the Institute Mutualiste Montsouris system for the stratification of laparoscopic liver resections: an international multicenter study	7
Screening for pancreatic cancer in individuals with genetic susceptibility	7
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	6
Feasibility and outcomes of robotic partial pancreatoduodenectomy	6
ESMO 2023 pancreatic cancer guidelines signal stepwise progress	6
De-escalating surgical treatment in low stage gallbladder cancer	6
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy	6
Massive hepatic hemangioma complicated by Kasabach-Merritt syndrome	6
Ethical issues in innovative clinical research	6
Frailty assessed using the Liver Frailty IndexTM (LFI) is a risk factor for mortality in patients with advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab	6
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application	6
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?	6
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial	6
Ectopic hepatocellular carcinoma of the abdominal wall	6
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions	6
Eggplant-like pancreas: transformation in a year	6
A puzzling mixed cystic-solid mass at the hepatic hilum	6
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	6
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy	6
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care	6
Acute cholecystitis in older adults with multimorbidity: does surgery offer better outcomes?	6
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma	6
From local control to immune synergy: the evolving role of stereotactic body radiotherapy in the immunotherapy era of hepatocellular carcinoma	6
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging	6
Can artificial intelligence deliver on the promise of precision medicine?	5
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology	5
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue	5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white	5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery	5
How to deliver palliative care for patients with management in decompensated cirrhosis	5
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?	5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions	5
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases	5
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study	5
Non-invasive strategies to predict post-hepatectomy liver failure	5
The lymphatic vessels of the liver observed by Frederik Ruysch	5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis	5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl	5
Chinese clinical guidelines for the diagnosis and treatment of sarcopenia in liver transplant recipients	5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation	5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision	5
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy	5
Nutritional management guidelines for pancreatitis—a commentary	5
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease	5
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?	5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges	5
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy	5
Textbook outcome after robotic vs. laparoscopic hepatectomy: a secondary post-hoc analysis of the randomized ROC‘N’ROLL trial	4
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach	4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?	4
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts	4
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection	4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study	4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer	4
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure	4
The difficulty of medical decision-making: should patients be involved?	4
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?	4
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	4
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer	4
Associations between metabolic dysfunction-associated steatotic liver disease and adverse clinical outcomes in chronic kidney disease: a prospective cohort study	4
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass	4
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen	4
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide	4

Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?	4
Exocrine pancreatic insufficiency: more compromise than precision	4
Sclerosing epithelioid mesenchymal neoplasm of the pancreas: a rare mimicker of common pancreatic neoplasms	4
Beyond precision: why time and human judgment still matter in the era of autonomous surgery	4
Ascites and complications: getting to the root of the trouble	4
D’Agoty’s early anatomical painting of the liver	4
Hepatic metastases in ovarian cancer	4
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation	4
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma	4
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation	4
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma	4
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth	4
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer	4
Machine learning-enhanced radiomics for predicting portal vein thrombectomy in liver transplantation	4
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial	4
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort	4
The gut-liver axis: connecting carotenoids to non-alcoholic fatty liver disease prevention—a promising pathway for future research	3
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume	3
Surgical treatment strategies for multifocal hepatocellular carcinomas	3
Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study	3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility	3
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines	3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy	3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?	3
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member	3
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis	3
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?	3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease	3
Robotic-assisted cholecystectomy: stepping stone to expertise or vogue?	3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma	3
Torsion of accessory liver lobe	3
Novel application of Yttrium-90 microsphere selective internal radiation therapy in hepatic metastases of primary fallopian tube carcinoma	3
Liver anatomy by Francis Glisson	3
Modified T category for early-staged intrahepatic cholangiocarcinoma: inclusion of perineural invasion	3
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians	3
Assessing the financial and equity implications of the 2020 liver allocation policy change	3
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies	3
A journey of a thousand miles begins with one small step	3
“PUMC’s Three Treasures”: can their glory remain?	3
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?	3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option	3
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches	3
The era of minimally invasive pancreatic surgery: is the robot ready to replace laparoscopy for extended left pancreatectomy?	3
Definition, risk factors, and outcomes of early and late recurrence after curative resection for intrahepatic cholangiocarcinoma	3
Incomplete ablation vs. complete ablation for solitary hepatocellular carcinoma ≤5 cm: the 10-year survival analysis	3
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor	3
From algorithms to adaptive frameworks: from square to circle in hepatocellular carcinoma management	3
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches	3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment	3
Application of liver transplant techniques in complex liver surgery: modified techniques and preliminary results of complex liver resection using in-situ hypothermic portal perfusion without venovenou	3
Inhibition of ferroptosis by propofol injectable emulsion protects hepatocytes against ischemia/reperfusion injury	3
Advancing risk stratification in intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization: the promise of the NTAA model	3
Claude Bernard’s concept of sugar metabolism in the liver	3
Significant portal hypertension: porto-sinusoidal vascular disease associated with atypical Adams-Oliver syndrome	3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis	3
Guidelines towards comprehensive care in acute pancreatitis	3
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma	3
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision	3
Is liver resection necessary for T2 gallbladder cancer?	3
The global burden of fatty liver disease: the major impact of China	3
Modern surgical approach to hepatocellular carcinoma	3
Diaphragmatic hernia following right hemihepatectomy	3
Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma	3
The burden and forecasts for metabolic dysfunction-associated fatty liver disease among adolescents and young adults in the Arab region	3
First reported post-transplant lymphoproliferative disorder after combined heart-liver transplantation	3
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	3